- Oops!Something went wrong.Please try again later.
Achiko AG / Key word(s): Miscellaneous
Achiko AG - Publication of Annual Report and Annual Financial Statements 2021 to Occur by 31 May 2022
Zurich, 29 April 2022: Ad hoc announcement pursuant to Art. 53 LR - Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) ("Achiko", the "Company") announces that Achiko will publish its annual report and its annual financial statements for the year 2021 on 31 May 2022 at the latest. As a company listed on SIX, Achiko is required to publish its annual report, together with the annual financial statements, within four months of the balance sheet date. Due to the Covid-19 pandemic, new staffing and training under difficult conditions in consequence of measures taken by several countries required a lot of management capacity. As a result, the publication of the annual report, together with the annual financial statements, as of 31 December 2021 will occur in the month of May 2022. Achiko has filed an exemption request with SIX Exchange Regulation (SER) regarding the publication of the annual report and the annual financial statements 2021. On 28 April 2022, SER granted Achiko the requested extension.
As required by SER, Achiko hereby reprints para. I of SER's respective decision:
I. The exemption application of Achiko (Issuer) dated 27 April 2022 requesting an extension of the deadline to publish its 2021 annual report and to file such report with SIX Exchange Regulation AG until 31 May 2022 at the latest is granted with the following reservation (lit. a) and under the following conditions (lit. b and c):
a. SIX Exchange Regulation AG reserves the right to suspend trading of the registered shares of the Issuer in case its 2021 annual report is not published in accordance with the provisions on ad hoc publicity (Art. 53 of the Listing Rules [LR] in connection with the Directive on Ad hoc Publicity [DAH]) and not filed with SIX Exchange Regulation AG until Tuesday, 31 May 2022, 11.59 pm CET, at the latest
b. Achiko is required to publish a notice in accordance with the provisions on ad hoc publicity (art. 53 LR in connection with the DAH) concerning this decision until Friday, 29 April 2022, 7.30 am CET, at the latest. The notice must contain:
- the unaltered reproduction of the wording of para. I. of this decision, placed in a prominent position;
- the reasons for the application of the Issuer requesting an extension of the deadline to publish its 2021 annual report and to file such report with SIX Exchange Regulation AG.
c. Achiko is required to publish a notice in accordance with the provisions on ad hoc publicity (art. 53 LR in connection with the DAH) concerning this decision until Thursday, 19 May 2022, 7:30am CET, at the latest. The notice must contain:
The next annual general meeting was intended to take place on 31 May 2022. Due to the later publication of the annual report 2021, the annual general meeting 2022 will take place at the end of June 2022.
ABOUT ACHIKO AG
Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameXTM and companion health apps via its digital mobile health technology division, Teman SehatTM. The AptameX DNA aptamer tests can be rapidly chemically synthesised, are cost-effective and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.
Headquartered in Zurich, Achiko has offices in Jakarta, and staff around the world.
Switzerland & Global
End of ad hoc announcement
SIX Swiss Exchange
EQS News ID:
End of Announcement
EQS News Service